Interleukin 15 Pharmacokinetics and Consumption by a Dynamic Cytokine Sink.

CD8+ T cells NK cells cytokine immuno-oncology interleukin-15 pharmacokinetics target-mediated drug disposition

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 03 06 2020
accepted: 07 07 2020
entrez: 9 9 2020
pubmed: 10 9 2020
medline: 13 4 2021
Statut: epublish

Résumé

Interleukin-15 (IL-15) is crucial for the proliferation and survival of NK and CD8

Identifiants

pubmed: 32903632
doi: 10.3389/fimmu.2020.01813
pmc: PMC7438588
doi:

Substances chimiques

Immunologic Factors 0
Interleukin-15 0
Receptors, Interleukin-15 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1813

Informations de copyright

Copyright © 2020 Hangasky, Waldmann and Santi.

Références

Biomed Pharmacother. 2019 Apr;112:108677
pubmed: 30798123
Front Immunol. 2020 May 19;11:868
pubmed: 32508818
Blood. 2011 May 5;117(18):4787-95
pubmed: 21385847
Cytokine. 2018 Jul;107:105-112
pubmed: 29452720
Clin Cancer Res. 2019 Aug 15;25(16):4945-4954
pubmed: 31142503
MAbs. 2014 Jul-Aug;6(4):1026-37
pubmed: 25072059
Swiss Med Wkly. 2019 Jan 23;149:w14697
pubmed: 30673115
J Biol Chem. 2013 Jun 21;288(25):18093-103
pubmed: 23649624
Clin Cancer Res. 2018 Nov 15;24(22):5552-5561
pubmed: 30045932
Expert Opin Biol Ther. 2020 Jul;20(7):705-709
pubmed: 32159390
Oncoimmunology. 2017 Jan 11;6(3):e1277306
pubmed: 28405498
J Clin Oncol. 2015 Jan 1;33(1):74-82
pubmed: 25403209
J Immunol. 2003 May 15;170(10):5018-26
pubmed: 12734346
Mol Cancer Ther. 2009 Sep;8(9):2736-45
pubmed: 19723883
J Exp Med. 2002 Oct 7;196(7):935-46
pubmed: 12370255
Cancer Immunol Res. 2016 Jan;4(1):49-60
pubmed: 26511282
Blood. 2011 Dec 22;118(26):6845-8
pubmed: 22067383
Nat Rev Immunol. 2006 Aug;6(8):595-601
pubmed: 16868550
Gynecol Oncol. 2017 Jun;145(3):453-461
pubmed: 28236454
Clin Cancer Res. 2018 Apr 1;24(7):1525-1535
pubmed: 29203590
Immunol Lett. 2017 Oct;190:159-168
pubmed: 28823521
Clin Cancer Res. 2018 Jul 15;24(14):3325-3333
pubmed: 29463551
Cytokine. 2011 Dec;56(3):804-10
pubmed: 22019703
J Biol Chem. 2006 Jan 20;281(3):1612-9
pubmed: 16284400
Cytokine. 2018 Aug;108:213-224
pubmed: 29402721
Blood. 2005 Oct 1;106(7):2302-10
pubmed: 15976182
Blood. 2018 Jun 7;131(23):2515-2527
pubmed: 29463563
Biochem Pharmacol. 2006 Jun 28;72(1):1-10
pubmed: 16469301

Auteurs

John A Hangasky (JA)

ProLynx, San Francisco, CA, United States.

Thomas A Waldmann (TA)

Lymphoid Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, MD, United States.

Daniel V Santi (DV)

ProLynx, San Francisco, CA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH